Pie Medical nets approval for phase-contrast angio MR software
Pie Medical Imaging has received FDA clearance for its cardiovascular angiography analysis system (CAAS) MR Flow.
The Maastricht, the Netherlands-based Pie said its CAAS MR Flow software enables health professionals to perform analysis of phase-contrast angiography (PCA) MR images. PCA images are used for quantitative assessment of blood flow and velocity.
The company said it features one-click vessel edge detection and contour propagation; analysis of four regions per flow series; direct comparison of multiple flow series in a single study; and anatomical designations for direct calculation of clinical results.
The Maastricht, the Netherlands-based Pie said its CAAS MR Flow software enables health professionals to perform analysis of phase-contrast angiography (PCA) MR images. PCA images are used for quantitative assessment of blood flow and velocity.
The company said it features one-click vessel edge detection and contour propagation; analysis of four regions per flow series; direct comparison of multiple flow series in a single study; and anatomical designations for direct calculation of clinical results.